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Rahsan Ilikci SagkanAbstract
Background: Momordica charantia (MC) is a tropical plant that is extensively used in folk medicine. However, the
knowledge about side effects of this plant is relatively little according to knowledge about its therapeutic effects.
The aim of this study is to reveal the effects of non-allergic type-I like hypersensitivity to MC by an experiment
which was designed in vitro.
Methods: In the present study, the expression of CD63 and CD203c on peripheral blood basophils against different
dilutions of MC extracts was measured using flow cytometry and compared with one another. In addition to this,
intra-assay CV’s of testing extracts were calculated for precision on reproducibility of test results.
Results: It was observed that the fruit extract of MC at 1/100 and 1/1000 dilutions significantly increased active
basophils compared to same extract at 1/10000 dilution.
Conclusions: In conclusion, Momordica charantia may elicit a non-allergic type-I like hypersensitivity reaction in
especially susceptible individuals.
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Momordica charantia (MC) as a member of Cucurbita-
ceae family has been grown in many tropical and subtrop-
ical countries and also known as bitter melon or bitter
gourd [1]. This plant has traditionally been used as herbal
medicine since ancient times. The therapeutic effects of
this plant make it a promising candidate for development
of future drugs [2]. Hence the research on drug develop-
ment has been focused on investigating biochemical and
pharmacological properties of this plant [3]. In this con-
text, the numerous studies demonstrate that MC has lots
of active plant chemicals such as triterpenes, proteins and
steroids [4]. Accordingly, it was shown in experimental
and clinical studies that each part of MC such as seed,
fruit and leaf are potentially effective for treatment of vari-
ous diseases such as infections, cancer, diabetes, ulcer etc
[3,5,6]. Although bitter melon has not been known with
its harmful side effects, the relatively low toxicity with oral
intake was experienced in some in vivo studies [7].Correspondence: rilikci@gata.edu.tr
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reproduction in any medium, provided the orThe effects of MC on immune system cells were investi-
gated by many studies in vivo and in vitro in order to
explain the mechanisms of curative effects on diseases.
Anti-infectious and anti-cancer effects of MC were clari-
fied by augmentation of natural killer (NK) cell-mediated
cytotoxicity and interferon-gamma production [8,9]. Bitter
melon has a protein called Momordica anti-human immu-
novirus protein (MAP30) which is not only activates nat-
ural killer cells but also increases production of interferon
gamma that fights all types of viruses. MAP30 has also
capable of inhibiting infection of HIV type 1 (HIV-1) in T
lymphocytes and monocytes [10]. This plant also leads to
a decrease in the number of lymphocytes, increases in the
populations of T helper cells and NK cells, and an increase
in the immunoglobulin production of B cells [11].
It drew our attention to that although many experimen-
tal studies has been performed to reveal the effects of MC
on immune functions, there is not any striking report in
the literature that investigate the possible side effects of
non-allergic type-I like hypersensitivity to MC and each
mechanism by using immunological methods. Therefore,
we decided to design an experimental study in order to
show at least the effects of MC on basophils which play aLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to stimulation. Briefly, the aim of this study was to investi-
gate the response of basophils to MC plant extracts meas-
uring the expression levels of CD63 and CD203c activation
markers and to evaluate the risk of non-allergic type-I like
hypersensitivity reaction to this plant. Flow cytometric ana-
lysis, a valuable and safe method for quantitative measure-
ment of basophil activation, was used for this purpose [12].
Methods
Plant collection
The Momordica charantia L., Sp. PL.2:1009 (1753) plant
was collected from the Ida mountains in August 2011. The
species was characterized by Prof. Dr. Gulendam Tumen
from Deparment of Biology, University of Balikesir. 60515
was given as a herbarium voucher specimen at the Univer-
sity of Ankara (ANK). Herbarium specimen was prepared
and deposited at the Department of Biology, Faculty of
Science, University of Ankara.
Plant material extraction and preparing of dilutions
The seeds and fruits chopped from this plant were pow-
dered by blender and dried in air. The essence of seeds
and fruits of the plant were extracted separately by using
hexane as solvent as described in previous report [1].
The same method was followed for extraction process of
both components of bitter melon. In extraction process,
each component were added to hexane in separate con-
tainers and heated overnight to obtain crude extract.
After evaporation of hexane, the crude extract was dis-
solved in heptane and isolated from solvent by evapor-
ation under vacuum conditions. For fruit extraction of
bitter melon, a stock solution with a concentration of
161 mg/ml was prepared and this stock underwent 100
(1.61 mg/ml) to 10000 (0.0161 mg/ml) fold dilution to
prepare 3 sets of samples of different concentration. For
seed extraction of the plant, the same dilution procedure
was applied to a concentration of 210 mg/ml to prepare
3 sets of dilutions (2.1, 0.21, 0.021 mg/ml).
Whole blood samples
Three healthy and voluntary individuals (1 male, 2 female)
were enrolled into registered for the study. Their ages
were 27, 33 and 38, respectively. They did not have any
acute or subacute inflammatory conditions, chronic illness
including metabolic disorders or continuous drug use. Five
milliliter of whole blood from each donor was drawn to
anticoagulant EDTA tubes at run-time.
Ethical approval
This study was conducted in conformity to the Helsinki
Declaration and approved by the local ethics committee
of Keçiören Training and Research Hospital. B.10.4.
İSM.4.06.68.49/279 was given as a protocol number. Allparticipants in my this study were volunteered and each
participant agreed with their consent voluntarily).Basophil activation test
Basophil activation test (BAT) was carried out from whole
blood including anticoagulant EDTA using flow cytomet-
ric allergen stimulation test (FlowCAST) (Bühlmann La-
boratories, Schönenbuch, Switzerland) according to the
manufacturer’s protocol. The staining reagents were con-
taining a mixture of monoclonal antibodies to human
CD63 and CD203c both labeled with PE-DY647, and a
monoclonal antibody to CCR3 (as a selective marker for
basophils) labeled with PE.
Various concentrations were prepared from both seed
and fruit extracts of bitter melon that were used for test-
ing of stimulation capability of MC on basophils. For this
purpose, A 100 μl of each concentrations of extracts and
negative (stimulation buffer)/positive controls (anti-FcεR1
monoclonal antibody, fMLP) were added into the sample
tubes. 200 μl of stimulation buffer was mixed with samples
and 100 μl of whole blood, 40 μl of staining reagent were
added and then, all test tubes were incubated at 37°C for
10 min. After the incubation step, samples were allowed
for eritrocyte lysing by adding 2 ml 1× lysing solution for
10 min at room temperature. Samples with lysed cells
were centrifuged for 5 min at 500×g. Supernatant was dis-
carded and pellet was resuspended with 300 μl wash buf-
fer. Before monitoring, 800 μl wash buffer was added into
each test tube. Flow cytometry was utilized for analysis of
process sample (FACSCanto II, BD Bioscience, San Jose,
CA using FACSDiva 5.02. software). In the low side scatter
and high CCR3, positive basophil population was gated.
500 to 1000 basophil events were counted (Figure 1).
Basophils were represented by expression of CD63 and
CD203c (CD63 + CD203c+) were evaluated as active
cells. Stimulation levels were quantified as either per-
centages of active basophils or mean fluorescence
intensity (MFI) of dual stained basophils.Experimental design
Initially, a serial dilution of both fruit and seed extracts
of bitter melon MC were prepared for experimental
procedure as mentioned before. In the first step of the
experiment, stimulation levels at three different dilutions
of MC were measured in three healthy individuals, and
statistically compared with one another. Thereafter, in
the second step of the experiment, the measurements
which were obtained from different individuals at the
same dilution of MC were taken into account as though
obtained same individual. Thus, the combined measure-
ments at different dilutions of MC were statistically
compared with one another.
Q2: 46.4 %




dilution of MC (d) 1/100 (e) 1/1000 dilution of MC  (f) 1/10000 dilution of MC  
Q2: 1.1 %
Q2: 7.0 %Q2: 63.5 % Q2: 10.2 %
Figure 1 The dot-plots from single representative experiment obtained with a healthy individual. The basophil population was gated in
an SSC-CCR3 dot plot (a) and analyzed for CD63 and CD203c. The percentages represent the percentage (%) of positive cells in the appropriate
quadrant. The percentages of CD63 + CD203c + basophils in negative control (stimulation buffer-background) (b), positive control (Anti-FcεR1)
(c) and whole bloods stimulated with fruit extracts of MC at 1/100 (d), 1/1000 (e) and 1/10000 (f) dilutions.
Ilikci Sagkan BMC Complementary and Alternative Medicine 2013, 13:284 Page 3 of 5
http://www.biomedcentral.com/1472-6882/13/284Intra-assay coefficients of variability
We calculated intra-assay CV’s for both controls and test-
ing extracts in order to express the precision and reprodu-
cibility of BAT results. While the intra-assay CV’s which
were calculated from the results of negative and positive
controls, were in acceptable range (less than 10), testing
extracts were not. We thought that some problems related
to extraction procedure or solvents might lead to these
unfavorable results [13-15].
Intra-assay coefficients of variability (CV) for this
experimental study was separately calculated from the
percentages of active basophils in 7 replicates prepared
from peripheral blood samples of three healthy individ-
uals for stimulation buffer (background-negative control),
stimulation controls (anti-FcεR1 monoclonal antibody,
fMLP) and fruit extracts of MC within the same run.
Results were expressed as% CV.Table 1 Stimulation levels of basophils in three healthy indiv
Individuals 1/100
% MFI %
1 37.7(49.4) 1414(1381) 5.6
2 37.0(28.5) 882(1078) 6.0
3 57.0(57.0) 1238(1639) 8.2
Data were expressed as median (range).Statistical analysis
All statistical analyses were performed using computer soft-
ware (SPSS for Windows version 11.5, SPSS Inc., Chicago,
IL, USA). For the tests of normality, we used Kolmogorov-
Smirnov test. The Friedman test was used for multiple
statistical comparisons. The Wilcoxon test was used as
a post hoc test in order to see whether the Friedman
test is statistically significant. In order to investigate the
relations between the variables, we used Spearman’s
rank correlation test. A p value < 0.05 was considered to
be statistically significant.
Results and discussion
Intra-assay coefficients of variabilities (CV’s) were found to
be 4.2%, 5.4% and 7.6 for stimulation buffer (background-
negative control) and stimulation controls (anti-FcεR1
monoclonal antibody, fMLP), respectively. However, intra-iduals
1/1000 1/10000
MFI % MFI
(6.2) 1112(1857) 6.9(10.7) 234(595)
(8.1) 654(703) 9.0(8.3) 152(123)
(6.1) 932(877) 9.9(13.7) 345(698)
Table 2 Stimulation levels of basophils in combined
measurements
1/100 1/1000 1/10000
% MFI % MFI % MFI
42.1(79.9) 1187(2227) 6.2(8.3) 988(1892) 8.0(13.7) 212(728)
Data were expressed as median (range).
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33.0%, 48.6, respectively) were higher than those of negative
and positive controls.
No significant alteration regarding basophil activation
was observed in the experiments which was done with
seed extract of MC (data not shown). However, fruit
extract of MC had a striking in vitro effect on basophils.
Thus, the achieved results from this point were only
related to fruit extract of MC.
Stimulation levels at the same dilutions of MC were not
different from one another in three healthy individuals
(Table 1). Therefore, the combined measurements obtained
from three different individuals were considered for statis-
tical comparisons of measurements obtained from different
dilutions of MC. The stimulation levels obtained from 1/
100 dilution of MC were found to be higher than those of
1/1000 and 1/10000 dilutions of MC (Table 2, Figure 2).
Accordingly, the percentage of CD63 +CD203c + basophils
were higher at 1/100 dilution of MC than those of 1/1000
and 1/10000 dilutions of MC. However, no significant
difference was found between the percentages of CD63 +
CD203c + basophils at 1/1000 and 1/10000 dilutions of
MC. In addition, while MFI measurements were higher at
1/100 and 1/1000 dilutions of MC than those of a 1/10000
dilution of MC, there was not any significant difference
between first two dilutions. Positive correlations were found
regarding to MFI measurements between 1/100 and 1/1000Figure 2 Comparisons of stimulation levels of basophils (CD63 + CD2
combined 21 measurements of three healthy individuals, and given as perc
and extreme values. Horizontal bars represent median values. The differenc
Friedman Test. Wilcoxon Signed Rank test was used as post hoc test. p valu
was reached in comparisons.dilutions of MC and between 1/1000 and 1/10000 dilutions
of MC (p values: 0.029 and 0.027, respectively). However,
there was not any correlation with respect to the percent-
ages of CD63 +CD203c + basophils. These results support
that fruit part of bitter melon is potentially non-allergic
type-I like hypersensitivity due to stimulation of basophils
in vitro conditions.
In spite of discouragement in intra-assay CV’s from dif-
ferent dilutions of MC, significant differences with respect
to both percentages and MFI values obtained from BAT
were seen in statistical comparisons of different dilutions
of MC extracts prepared from fruit part. In addition, posi-
tive correlations between different dilutions of MC ex-
tracts were found regarding MFI measurements. However,
no significant difference in the same respects was found
among the comparisons of different dilutions of MC
extracts prepared from seed part. These results may be
explained with the effects of various constituents available
in different parts of bitter melon such as fruit, seed, leaf
and root [8]. The principal constituents are alpha and beta-
momorcharin in fruits, seeds and leaves; insulin-like poly-
peptides (p-insulin, alkaloid momordicine) in both the fruits
and seeds; steroid glycosides (momordin, charantin) in both
fruits and leaves; vicine and stearic-, linoleic-, and oleaic-
acids in seeds; iron, sodium, thiamine, riboflavin, niacin, and
ascorbic acid in leaves [16,17]. So indeed, all parts of bitter
melon have common beneficial and deleterious impacts
such as anti-infectious, anti-inflammatory, anti-cancer, anti-
diabetic, anti-ulcer, anti-fertility and low toxicity.
Despite the lack of detailed research on non-allergic
type-I like hypersensitivity effect of bitter melon, a few
reports that mention allergic properties of Cucurbitaceae
family exist in the literature [18-24]. Satar and Kloutsos
et al. reported cases which presented life-threatening03c+) in different dilutions of MC. Data were obtained from
entage (A) or MFI (B). Boxes show the ranges of 1st and 3rd quartiles
es among the measurements of different dilutions were evaluated by
es were indicated above the boxes when a level of significance < 0.05
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from using of Ecballium elaterium known as the wild cu-
cumber which is a plant indigenous to the Mediterranean
region [20,21]. Zucchini (Cucurbita pepo) which is also a
member of the Cucurbitaceae family, was studied by
Reindl et al. In the study of Reindl et al, allergic reaction
to this plant in 4 patients with oral allergy syndrome, nau-
sea, diarrhea, or pruritus were identified after the intake of
zucchini [22].
Conclusion
In conclusion, Momordica charantia or Bitter Melon, is a
tropical plant, has been consumed extensively in folk medi-
cine. The parts of this plant have similar or different effects
that are not only beneficial, but also harmful. There are
many handbook and website sources including knowledge
about bitter melon. However, further in vivo and in vitro
studies are needed in order to reveal many more unknown
properties of this plant including both therapeutic and
adverse effects.
Abbreviations
MC: Momordica charantia; MFI: Mean fluorescent intensity; BAT: Basophil
activation test.
Competing interests
The author declares that he has no competing interests.
Authors’ contribution
I have designed this study and have conducted all experiments, acquisition
and analyses of all flow cytometric data. I also drafted manuscript.
Acknowledgements
I wish to thank Professor Ugur MUSABAK for not only giving me the
opportunity to work in the laboratory but also his guidance in this
experimental study.
Received: 11 July 2013 Accepted: 24 October 2013
Published: 26 October 2013
References
1. Mahmood A, Raja GK, Mahmood T, Gulfraz M, Khanum A: Isolation and
characterization of antimicrobial activity conferring component(s) from
seeds of bitter gourd (Momordica charantia). J Med Plants Res 2012,
6(4):566–573.
2. Bano F, Akthar N, Naz H: Effect of the aqueous extract of Momordica
charantia on body weight of rats. J Basic Appl Sci 2011, 7(1):1–5.
3. Joseph B, Jini D: Antidiabetic effects of Momordica charantia (bitter
melon) and its medicinal potency. Asian Pac J Trop Dis 2013, 3(2):93–102.
4. Liu JQ, Chen JC, Wang CF, Qiu MH: New cucurbitane triterpenoids and
steroidal glycoside from Momordica charantia. Molecules 2009,
14(12):4804–4813.
5. Bakare RI, Magbagbeola OA, Akinwande AI, Ebuehi OA: Effect of aqueous
leaf extract of Momordica charantia on intestinal enzyme activities in
diarrhoeagenic mice. Nig Q J Hosp Med 2010, 20(1):24–28.
6. Alam S, Asad M, Asdaq SM, Prasad VS: Antiulcer activity of methanolic extract
of Momordica charantia L. in rats. J Ethnopharmacol 2009, 123(3):464–469.
7. Patil SA, Patil SB: Toxicological studies of Momordica charantia Linn. Seed
extracts in male mice. Int J Morphol 2011, 29(4):1212–1218.
8. Kumar DS, Sharathnath KV, Yogeswaran P, Harani A, Sudhakar K, Sudha P, Banji
D: A medicinal potency of Momordica charantia. IJPSR 2010, 1(2):95–100.
9. Cunnick JE, Sakamoto K, Chapes SK, Fortner GW, Takemoto DJ: Induction of
tumor cytotoxic immune cells using a protein from the bitter melon
(Momordica charantia). Cell Immunol 1990, 126(2):278–289.10. Lee-Huang S, Huang PL, Bourinbaiar AS, Chen HC, Kung HF: Inhibition of
the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV
plant proteins MAP30 and GAP31. Proc Natl Acad Sci USA 1995,
92(19):8818–8822.
11. Manabe M, Takenaka R, Nakasa T, Okinaka O: Induction of anti-
inflammatory responses by dietary Momordica charantia L.
(bitter gourd). Biosci Biotechnol Biochem 2003, 67(12):2512–2517.
12. Abuaf N, Rostane H, Rajoely B, Gaouar H, Autegarden JE, Leynadier F, Girot
R: Comparison of two basophil activation markers CD63 and CD203c in
the diagnosis of amoxicillin allergy. Clin Exp Allergy 2008, 38:921–928.
13. Silva LG, Lee IS, Kinghorm DA: Special Problems with the extraction of
Plants. In , Methods in BiotechnologyEdited by Cannell JPR. 1993:329–363.
14. McCloud TG: High throughput extraction of plant, marine and fungal
specimens for preservation of biologically active molecules.
Molecules 2010, 15:4526–4563.
15. Lapornik B, Prosek M, Wondra AG: Comparison of extracts prepared from
plant byproducts using different solvents and extraction time. J Food Eng
2005, 71:214–222.
16. Natural Medicines Comprehensive Database [online database]; 2013. Available
at: http://naturaldatabase.therapeuticresearch.com.
17. Braun L, Cohen M: Bitter melon. In Herbs & Natural Supplements. 2nd
edition. Marrickville: Elsevier; 2007:123–130.
18. Meng Y, Liu B, Lei N, Zheng J, He Q, Li D, Zhao X, Shen F: Alpha-
momorcharin possessing high immunogenicity, immunotoxicity and
hepatotoxicity in SD rats. J Ethnopharmacol 2012, 139(2):590–598.
19. Eken C, Ozbek K, Yildirim CK, Eray O: Severe uvular edema and nasal mucosal
necrosis due to Ecbalium elaterium (squirting cucumber): an allergic
reaction or direct toxic effect? Clin Toxicol (Phila) 2008, 46(3):257–258.
20. Satar S, Gokel Y, Toprak N, Sebe A: Life-threatening uvular angioedema
caused by Ecbalium elaterium. Eur J Emerg Med 2001, 8(4):337–339.
21. Kloutsos G, Balatsouras DG, Kaberos AC, Kandiloros D, Ferekidis E,
Economou C: Upper airway edema resulting from use of Ecballium
elaterium. Laryngoscope 2001, 111(9):1652–1655.
22. Reindl J, Anliker MD, Karamloo F, Vieths S, Wüthrich B: Allergy caused by
ingestion of zucchini (Cucurbita pepo): characterization of allergens and
cross-reactivity to pollen and other foods. J Allergy Clin Immunol 2000,
106(2):379–385.
23. Asero R, Mistrello G, Roncarolo D, de Vries SC, Gautier MF, Ciurana CL,
Verbeek E, Mohammadi T, Knul-Brettlova V, Akkerdaas JH, Bulder I, Aalberse
RC, Van Ree R: Lipid transfer protein: a pan-allergen in plant-derived
foods that is highly resistant to pepsin digestion. Int Arch Allergy Immunol
2000, 122(1):20–32.
24. Fritsch R, Ebner H, Kraft D, Ebner C: Food allergy to pumpkinseed–
characterization of allergens. Allergy 1997, 52(3):335–337.
doi:10.1186/1472-6882-13-284
Cite this article as: Sagkan: An in vitro study on the risk of non-allergic
type-I like hypersensitivity to Momordica charantia. BMC Complementary
and Alternative Medicine 2013 13:284.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
